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Abstract
Background: Cognitive behavioral therapy is treatment of choice for insomnia, but availability is scarce. Self-help
can increase availability at low cost, but evidence for its efficacy is limited, especially for the typical insomnia
patient with co-morbid problems. We hypothesized that a cognitive behaviorally based self-help book is effective
to treat insomnia in individuals, also with co-morbid problems, and that the effect is enhanced by adding brief
therapist telephone support.
Methods: Volunteer sample; 133 media-recruited adults with insomnia. History of sleep difficulties (mean [SD]) 11.8
[12.0] years. 92.5% had co-morbid problems (e.g. allergy, pain, and depression). Parallel randomized (block-
randomization, n ≥ 21) controlled “open label” trial; three groups-bibliotherapy with (n = 44) and without (n = 45)
therapist support, and waiting list control (n = 44). Assessments before and after treatment, and at three-month follow-
up. Intervention was six weeks of bibliotherapeutic self-help, with established cognitive behavioral methods including
sleep restriction, stimulus control, and cognitive restructuring. Therapist support was a 15-minute structured telephone
call scheduled weekly. Main outcome measures were sleep diary data, and the Insomnia Severity Index.
Results: Intention-to-treat analyses of 133 participants showed significant improvements in both self-help groups from
pre to post treatment compared to waiting list. For example, treatment with and without support gave shorter sleep
onset latency (improvement minutes [95% Confidence Interval], 35.4 [24.2 to 46.6], and 20.6 [10.6 to 30.6] respectively),
and support gave a higher remission rate (defined as ISI score below 8; 61.4%), than bibliotherapy alone (24.4%, p’s<
.001). Improvements were not seen in the control group (sleep onset latency 4.6 minutes shorter [-1.5 to 10.7], and
remission rate 2.3%). Self-help groups maintained gains at three-month follow-up.
Conclusions: Participants receiving self-help for insomnia benefited markedly. Self-help, especially if therapist-
supported, has considerable potential to be as effective as individual treatment at lower cost, also for individuals
with co-morbid problems.
Trial Registration: ClinicalTrials.gov: NCT01105052
Background
In the general population, about one third suffers from
one or more symptoms of insomnia, and about 10% ful-
fill the criteria for a clinical diagnosis [1]. Insomnia
entails substantial individual suffering, and costs to
society [2] through factors such as drug-use, increases
in risks for long-term sick-leave, major depression, and
hypertension [3-6].
Despite the high prevalence and negative conse-
quences of insomnia, only a small percentage is treated
[7,8], most commonly with pharmacotherapy [8]. How-
ever, many individuals with insomnia would prefer non-
pharmacological treatment if available [9,10]. Cognitive
behavioral therapy (CBT) has been shown to be effective
for insomnia [11-13], and is therefore considered treat-
ment of choice [14,15]. Still, CBT is provided only to a
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any medium, provided the original work is properly cited.minority, at least partially due to the limited availability
of CBT therapists [16] and high initial costs [17].
To improve the availability of effective psychological
treatments, self-help protocols have been developed for
a number of problems, including anxiety, depression,
and tinnitus [e.g. [18]]. Evaluations have often shown
results comparable to face-to-face treatments [19], while
self-help treatments are most likely more cost-effective
[20,21]. Although thorough health-economic studies on
the cost-effectiveness of self-help are still in their
infancy, the potential for helping more people to a
lower cost is obvious. Self-help protocols have been
developed also for insomnia, and in a recent meta-analy-
sis, Van Straten & Cuijpers concluded they are effective
for individuals with primary insomnia [17].
However, the majority of patients with insomnia pre-
sent with a range of co-morbid problems [22]. In earlier
studies, these patients were often excluded, since other
states such as psychiatric conditions and medical pro-
blems including other sleep disorders were considered
to cause the insomnia.
This exclusion reduces the generalizability of the
empirical support for CBT for insomnia since insomnia
only rarely occurs without co-morbid conditions [23].
For example, in one study where insomnia diagnoses
were assessed, only 20% of the participants were diag-
nosed with primary insomnia, while 52% were diagnosed
with insomnia secondary to a mental disorder (44%) or
to a medical condition or substance abuse (8%) [24].
The causal direction of the different conditions is
often very difficult to establish, possibly due to bi-direc-
tional relationships between insomnia and other disor-
ders. Hence, it has been suggested that the term co-
morbid (rather than secondary) insomnia be used and
that it may not be necessary to treat the “other” disorder
first [25]. Indeed, in a recent RCT, Edinger et al [26]
showed that CBT for insomnia delivered individually is
useful also for patients with co-morbidities, and a rela-
tively recent review concludes that CBT for insomnia
(delivered individually or as group treatments) is pro-
mising for individuals with medical and psychiatric co-
morbidity [27]. By contrast, data is very limited on self-
help treatments for this broader population of insomnia
sufferers. It is therefore crucial to find out if the pre-
vious positive results shown for individuals with primary
insomnia without co-morbidities, also generalize to the
larger group of patients including those with co-
morbidities.
Therapist guidance can improve the effects of self-help
treatments and reduce drop-out rates [21,28]. This
seems true also for self-help CBT for insomnia [17],
although the few studies comparing self-help with and
without therapist guidance are limited by rather low
power and have excluded individuals with co-
morbidities [29,30]. It is also unclear whether the differ-
ences between guided and unguided participants seen
directly after treatment are stable over time. In addition,
previous evaluations of insomnia treatments have
focused mainly on sleep-timing measures, while studies
investigating effects of insomnia treatments on daytime
functioning and psychological distress are lacking.
The objective of the present study was to compare the
effects of a CBT-based self-help treatment for insomnia,
given with or without therapist support, to a waiting list
control group. To compensate for limitations in pre-
vious studies we wanted to study individuals from the
general population, including patients with co-morbid-
ities, and to also evaluate day time functioning and psy-
chological distress.
Our hypotheses were that participants would benefit
from treatment both directly after the treatment and at
three-month follow up, and that support would enhance
outcome. We hypothesized that these improvements
would be seen in response and remission rates, sleep
timing, subjective measures of sleep, and daytime func-
tioning. No differences in outcome due to co-morbid
problems were expected.
Methods
Design and Randomization
This study was a randomized controlled trial with three
arms. One-hundred and thirty three participants were
block-randomized (smallest block n = 21) by KB and SR
via a true randomization process http://www.random.
org to bibliotherapy with support (n = 44), to bibliother-
apy only (n = 45), or to the waiting list control group (n
= 44). Self report measures precluded blinding.
Ethics
This study was approved by the Regional Ethical Review
Board in Stockholm on February 2, 2008, identification
number 2008/23-31/4.
Participants
Participants were recruited from all over Sweden,
through media and websites. Interested individuals were
directed to a web-site with a description of the study,
informed consent and screening forms. All assessments
were conducted on the Internet or telephone. No mone-
tary compensation was given for participation, but the
participants did not pay for the treatment.
Inclusion criteria were: be at least 18 years old; meet
research diagnostic criteria (RDC) for insomnia accord-
ing to the American Academy of Sleep Medicine [31];
have insomnia at a clinical level defined as more than
10 points on the Insomnia Severity Index (ISI) [32];
duration of insomnia more than four weeks, have ade-
quate Swedish language skills; have access to a computer
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assessments and treatment during the course of the
study; absence of other sleep disorders that require
other treatment (e.g. sleep apnea); no severe somatic or
psychiatric disorder that temporally precedes insomnia
onset and from the patient’s point of view is the only
cause of insomnia, contraindicative of the treatment (e.
g. bipolar disorder), or require other treatment that can-
not be combined with this insomnia treatment; no
severe depression (defined as > 30 points on MADRS-S,
see below) or suicidality (≥ 4 points on MADRS-S, item
9); no severe alcohol or drug dependence; no night shift
work; no ongoing other insomnia treatment or previous
CBT for insomnia; not having a self-help book for
insomnia based on CBT techniques at home. Individuals
were not excluded due to using sleep medications.
The inclusion criteria were assessed from screening
forms and telephone interviews. If diagnoses or cut-offs
were ambiguous, they were discussed in clinical supervi-
sion (SJ), and if needed, complementary data was gath-
ered through an additional telephone interview.
Co-morbid insomnia
In the present study, insomnia diagnosis was assigned
following a structured interview based on the clinical
interview developed by Morin & Espie [33], translated
into Swedish, and with the addition of RDC for insom-
nia [31]. The interview also included questions regarding
the other inclusion criteria (see above), e.g. current and
previous medical, psychiatric and psychological diag-
noses and problems, and sleep medication use. One sec-
tion also included individually tailored questions for
clarifying any uncertainties from the screening forms.
Based on these interviews, interviewees were assigned a
diagnosis of primary insomnia (PI) or co-morbid insom-
nia (CMI). Those diagnosed with PI met RDC for pri-
mary insomnia and had no findings on the structured
interview suggesting a medical, psychiatric or medica-
tion cause for their insomnia. Participants assigned a
CMI diagnosis met RDC criteria for insomnia disorder
and had findings on the structured interview suggesting
their insomnia be at least partially resulting from or
affected by a concurrent active psychiatric or medical
problem, insomnia was a central complaint and was not
attributed exclusively to the other disorder. Patients who
met RDC critera for insomnia and had a co-morbid
condition, but where the insomnia was not the primary
complaint and was attributed exclusively to the other
disorder (be it sleep, medical, or psychiatric) were
excluded from this study.
The screening for sleep apnea received special atten-
tion, since apnea frequency and/or severity can increase
as a result of the sleep deprivation often following the
so called sleep restriction (or sleep compression) used
during CBT-treatment of insomnia. The ESS scale (see
below) and two structured questions on snoring and
apneas were used in the interview. When indicative of
sleep apnea, follow-up questions were made and indivi-
duals with plausible or diagnosed sleep apnea were
excluded and, if not already in treatment, referred to a
sleep medicine clinic.
Intervention
The self-help book [34] is based on well-established
CBT-models and techniques [32,35], and has two parts.
The first part consists of psycho education about sleep
and insomnia, including a simplified model for insomnia
and three exemplary cases. The second part presents
techniques, e.g. relaxation and visualization techniques,
sleep restriction and stimulus control, cognitive restruc-
turing techniques, and sleep hygiene. The techniques
are presented under headings such as Stress-Relief,
Work on Thoughts, and Help Your Sleep-Rhythm. One
section aims to analyze the reader’sp e r s o n a ls i t u a t i o n
using a Sleep Diary and a so called Treatment Guide
designed to help determining which techniques to focus
on. The treatment guide primarily suggests using the
techniques sleep restriction and stimulus control. Sleep
restriction instructions include setting a sleep window
to number of hours slept during the previous 4-7 nights
based on sleep diary recordings (no lowest limit given),
fixating the wake-up time, and increasing the scheduled
time in bed with 15 minutes contingent on sleep effi-
ciency exceeding 85% during the last 4-7 days. A sepa-
rate chapter focuses on sleep medication and sleep
medication tapering. A CD with audio relaxation and
visualization exercises is included. The final chapter
focuses on relapse prevention.
Treatment phase
The book was sent to the participants in the two treat-
ment groups, together with a letter encouraging them to
start reading and working with the program as soon as
possible. Participants in the group without therapist sup-
port then worked independently during the six week
treatment period.
Participants in the group receiving therapist support
were contacted by telephone to schedule an appoint-
ment for each week of the treatment (i.e. six telephone
appointments), and were encouraged to start reading
the book, filling out the digital Treatment Guide and
Sleep Diary and e-mailing these to the therapist before
their first scheduled telephone appointment.
All telephone appointments were conducted using a
structured guide. For instance, the first appointments
focused on getting started, analyzing the patients’ situa-
tion, and setting a sleep window for sleep restriction,
and the final telephone appointment focused on relapse
prevention. Each appointment was kept to a maximum
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gress and homework assignments on a structured eva-
luation sheet.
Therapists in the present study were in their final year
of training as clinical psychologists. Adherence to the
treatment protocol was ascertained through the use of
the written therapist guide, the structured evaluation
sheet, and the self-help manual and supervision of
therapists by an experienced clinician (SJ).
Participants in the control condition received the
treatment book without support after the three-month
follow-up assessment.
Measures
All self-report questionnaires were filled out over the
Internet, which improves the quality of data since miss-
ing items are not accepted and type of input can be
automatically validated before data is submitted by the
participants. In addition, the relative anonymity of ques-
tionnaires on the Internet has been suggested to reduce
social desirability of respondents [36].
Primary outcome measures
The Insomnia Severity Index (ISI) [32] is a much used,
7-item patient-reported outcome measure assessing the
severity of initial, middle and late insomnia; sleep satis-
faction; interference of insomnia with daytime function-
ing; noticeability of sleep problems by others; and
distress about sleep difficulties. A 5-point scale (0-4) is
used to rate each item, yielding a total score of 0 to 28.
T h eI S Ih a sa d e q u a t ep s y c h o m e t r i cp r o p e r t i e sa n di s
sensitive to measuring treatment response [37]. Treat-
ment response and remission rates were calculated from
the ISI; as suggested by Morin et al [38], participants
were considered treatment responders if their ISI score
changed with 8 points or more compared to pre-assess-
ment, and as treatment remitters if their absolute ISI
score was less than 8.
Sleep timing was measured with a sleep diary [32], the
most widely used outcome measure in insomnia
research [39], and was recorded during one week at
each assessment point. The sleep diary includes registra-
tion of bed time, time of falling asleep, length of night
time awakenings, time of waking up and time of getting
out of bed. Means of the daily ratings were calculated
for sleep onset latency, wake after sleep onset, total
sleep time, and sleep efficiency.
Secondary outcome measures
The sleep diary was also used to gauge subjective sleep
quality, stress at bed time, and overall day-time func-
tioning. The latter included questions for day-time fati-
gue ("how tired you have felt today”), and positive day-
time ratings ("how alert/well functioning/happy you
have felt today”). Each of these items were rated from 0
‘n o ta ta l l ’ to 5 ‘very much so’ and the three positive
day-ratings were combined to a composite score
(Crohnbach’s alpha = 0.893). All subjective sleep mea-
sures and measures of day-time functioning were calcu-
lated as means over the week.
The Dysfunctional Beliefs and Attitudes about Sleep
(DBAS) is a 30-item self-report measure identifying
sleep disruptive cognitions [40]. Although developed as
a visual analogue scale, it was transformed into a Likert-
type scale with responses 0-10 for the use on a web-site.
Scores range is 0-300.
The Sleep-Related Behaviour Questionnaire (SRBQ) is
used to assess counter productive safety behaviors in
insomnia [41]. The scale has 32 items which are scored
between 1 (almost never) to 5 (almost always), yielding
a total score range of 32-160.
The Perceived Stress Scale-10 items (PSS-10) measures
the perceived stress in daily life [42,43]. The PSS-10 has
10 items with response alternatives 0 (never) to 4 (very
often). Total score ranges from 0-40.
The Clinical Outcomes in Routine Evaluation-Outcome
Measure (CORE-OM) evaluates general psychological
distress [44]. The 28-item scale used has response alter-
natives 0 (often) to 4 (almost all the time), yielding a
total score between 0 and 112.
Power calculation and sample size
Power estimates based on the effects found in previous
studies (e.g. [29], d = 0.6 to 1.0) suggested at least 44
participants in each group, for a power of 80%.
Statistical methods
One way ANOVAs and c
2 associations were used to
compare groups on background variables. To reduce the
risk of mass-significance due to the many outcome mea-
sures, repeated measures MANOVAs were initially con-
ducted with treatment group as between-subjects
variable. For the MANOVAs, the outcome variables
were combined into three conceptually coherent groups;
sleep timing, subjective sleep, and measures of day-time
functioning and psychological distress. Three MANO-
VAs were used for the pre- to post-comparison, and
three MANOVAs were used to compare pre- to follow-
up assessments. When a MANOVA showed significant
interaction, follow-up tests were performed with a 2 × 2
ANOVA for each separate outcome measure.
Due to significant pre-treatment differences in Total
Sleep Time (F(2,129) = 6.46, p = .002), DBAS (F(2,130) =
3.47, p = .034) and SRBQ (F(2,130) = 3.36, p = .038) hp
2-
values (Eta squared) were used to calculate between-
groups effect sizes for interactions, rather than using
Cohen’s d for between group differences. To estimate
within group changes, Cohen’sdw a su s e d .T oe v a l u a t e
e f f e c t so ft h eg e n e r a lb u r d e no fc o - m o r b i d i t yo no u t -
come, number of co-morbid problems was correlated
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test for the impact of specific co-morbid problems,
repeated measures ANOVAs were calculated with pre-
s e n c eo rn o n - p r e s e n c eo fe a c ho ft h em o s tp r e v a l e n t
problems as between-groups-factor, and with ISI as the
dependent variable at the three different time-points.
For all analyses of variance, Huynh-Feldt corrections
were applied when sphericity could not be assumed,
based on Mauchly’s Test of Sphericity. Thirteen outliers
were found in sleep diary data, and following the recom-
mendations by Tabachnick & Fidell [45], score alteration
was performed in order not to lose valuable data, but
lessen the impact of outliers. Analyses were conducted
using PASW statistics 17 and 18 (SPSS Inc. Chicaco,
Illinois).
Results
Attrition, drop-out, adherence and use of other
treatments
Attrition and drop-out at post- and follow-up assess-
ments were low (see Figure 1).
To measure adherence, participants in the treatment
groups estimated how many hours per week they had
spent on treatment and how much of the book they had
read during treatment. Participants in the treatment group
with support reported having read on average 84% (SD =
14%) of the book, and those in the group without support
77% (SD = 27%). Corresponding figures for time spent on
treatment were 6.8 (SD = 5.9) and 7.3 (SD = 12.1) hours
per week. There were no significant differences between
the groups on these adherence measures.
In the waiting list group, six participants sought other
treatments during the first period (from pre- to post-
assessments), and two during the second period (from
post-assessment to follow-up). In the group receiving
bibliotherapy with therapist support, only one partici-
pant sought another treatment during the first period,
and two during the second. In the bibliotherapy group
the corresponding figures were two and six participants
respectively. A trend for an association between number
of participants seeking other treatments, and group, is
seen for the first period (c
2 = 5.174, df = 2, p = .075, N
= 131), but not for the second. Data from these indivi-
duals is also included in the analyses.
Recruitment and baseline data
Table 1 presents baseline data of the 133 participants from
all over Sweden. Only 7.5% of included participants were
diagnosed with primary insomnia with no concurrent
active disorder or problem affecting sleep. Participants
reported on average 3.4 (SD = 2.3) co-morbid problems,
the most common diagnoses being allergic diseases
(57.9%), acute (31.6%) and chronic (15%) pain, stress
(29.3%), restless legs (25.6%), nightmares (24.8%), snoring
(23.3%), bruxism (21.8%), high blood pressure (15%), noc-
turia (11.3%), tinnitus (11.3%), depression (11.3%), and
anxiety (10.5%). Using cut-off scores on MADRS-S, 30.3%
of participants suffered from mild depression (MADRS-S
13 -19), and 23.3% would have been diagnosed with major
depressive disorder (MADRS-S 20-30). Neither the num-
ber of co-morbid problems or presence of any specific
problem, nor any of the background variables, differed
between the three groups (see below). However, sleep
medication use was significantly higher in the waiting list
control group compared to the group receiving bibliother-
apy without support.
Participants were enrolled and screened between Feb-
ruary 26
th and March 30
th 2008. Pre-treatment assess-
ments were conducted between March 27
th and April
28
th, post-treatment assessments between May 22
nd and
June 13
th, and follow-up between September 11
th and
October 27
th, all in 2008.
Numbers analyzed
Except correlations and ANOVAS analyzing effects of
co-morbidity, all outcome analyses are computed for
439 Potential 
participants screened 
on webpage 
161 Invited to pre-
treatment 
assessments  
202 Excluded  
123 did not meet inclusion criteria 
36 non responsive 
43 declined further participation 
237 Interviewed 
76 Excluded after interview 
53 did not meet inclusion criteria  
23 declined further participation  
26 did not finish pre-treatment assessments 
2 declined further participation 
133 Randomized 
Waiting list  
Control (n=44) 
Bibliotherapy (n=45) 
1 drop-out from 
treatment;  
1 questionnaire & 
3 diaries lost to 
post-assessment  
2 drop-outs from 
treatment;  
1 questionnaire & 
7 diaries lost to 
post-assessment  
1 diary at pre-
treatment lost due 
to poor data 
quality  
5 questionnaires & 
8 diaries lost to 
post-assessment 
Post-assessment 
43 questionnaires 
41 sleep diaries 
44 interviews 
Post-assessment 
44 questionnaires 
38 sleep diaries  
45 interviews 
Follow-up assessment 
41 questionnaires  
40 sleep diaries  
44 interviews 
Follow-up assessment 
39 questionnaires 
37 sleep diaries  
44 interviews 
Post-assessment 
39 questionnaires 
36 sleep diaries  
43 interviews 
Bibliotherapy with therapist  
telephone support (n=44) 
3 questionnaires &  
4 diaries lost to 
follow-up 
assessment  
6 questionnaires & 
8 diaries lost to 
follow-up 
assessment  
5 questionnaires & 
5 diaries lost to 
follow-up 
assessment  
Follow-up assessment 
39 questionnaires 
39 sleep diaries  
41 interviews 
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Figure 1 CONSORT Flow chart. Participant flow throughout the
study.
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ward, based on 133 pre-assessment questionnaires and
132 pre-assessment sleep diaries (one in the control
group lost due to poor data quality).
Primary outcomes
Treatment response and remission rates
As seen in Figure 2, there were very few responders and
remitters in the waiting list control group (1 (2.27%) for
both variables), more in the bibliotherapy group (15
(34.9%) and 11 (24.4%)), but by far the most responders
and remitters were seen in the group receiving bib-
liotherapy with therapist support (30 (68.2%) and 27
(61.4%)) at post-assessment. The differences between
groups remained at three-month follow-up, and were
significant both for post- and three-month follow-up
assessments (c
2 = 17.047-42.289, df = 2, all p’s < .001, N
= 133).
Sleep timing
Two MANOVAs were conducted with sleep diary data
concerning aspects of sleep timing (i.e. sleep onset
latency, wake after sleep onset, total sleep time, and
sleep efficiency) as dependent variables, the first com-
paring all three groups between pre- and post-treatment,
and the second between pre-treatment and three-month
follow-up. Both MANOVAs showed significant interac-
tions (pre-post: F(8, 252) =9 . 3 5 1 ,p = .000, hp
2 = 0.229;
pre-follow up: F(8, 252) = 3.785, p = .000, hp
2 = 0.107).
Separate analyses were performed to establish which
interactions were significant (see tables 2 and 3). From
pre- to post-assessments, bibliotherapy with therapist
support gave larger gains than did waiting in all sleep
timing measures except total sleep time, and also larger
gains in wake after sleep onset, and sleep efficiency,
compared to bibliotherapy. Bibliotherapy improved sleep
onset latency and sleep efficiency more than did waiting.
Table 1 Baseline Characteristics of Participants
Characteristic Bibliotherapy with support (n
= 44)
Bibliotherapy (n =
45)
Waiting list control (n
= 44)
Total (N =
133)
P
Value
a
Age, mean (SD), years 50.8 (11.8) 47.4 (13.3) 45.4 (16.0) 47.9 (13.9) .18
Women, No. (%) 33 (75) 36 (80) 40 (90.9) 109 (82) .14
Marital status, No. (%)
Married/living with partner 30 (68.1) 37 (82.2) 29 (65.9) 96 (72.2) .64
Separated/Divorced/Widowed 6 (13.6) 2 (4.4) 5 (11.4) 13 (9.8)
Singel/Other 8 (18.2) 6 (13.3) 10 (22.7) 24 (18.0)
Educational level, No. (%)
Compulsary school/Other 2 (4.5) 8 (17.8) 3 (6.8) 13 (9.8) .30
Upper secondary school 13 (29.5) 16 (35.6) 18 (40.9) 47 (35.3)
College/University 29 (65.9) 21 (46.7) 23 (52.3) 73 (54.9)
Current occuptaion
b, No.(%)
Work/Full time studies 27 (61.4) 30 (66.7) 25 (56.8) 82 (61.7) .63
On sick-leave 9 (20.4) 5 (11.1) 4 (9.1) 18 (13.5) .25
Unemployed 3 (6.8) 2 (4.4) 2 (4.5) 7 (5.3) .98
Retired 6 (13.6) 8 (17.8) 9 (20.5) 23 (17.3) .70
Works at home/On parental leave/
Other
9 (20.4) 5 (11.1) 6 (13.3) 20 (15.0) .44
Economic situation, No. (%)
Bad/Very bad 3 (6.8) 3 (6.7) 7 (15.9) 13 (9.8) .36
Neither good nor bad 13 (29.5) 8 (17.8) 14 (31.8) 35 (26.3)
Good/Very good 28 (63.6) 34 (75.6) 23 (52.3) 85 (63.9)
Depression level (MADRS) at screening,
mean (SD)
14.1 (6.38) 12.8 (6.05) 15.2 (5.85) 14.0 (6.13) .19
Insomnia Severity (ISI) at screening, mean
(SD)
18.2 (3.5) 18.3 (3.3) 18.3 (3.3) 18.3 (3.3) .99
History of Insomnia, mean (SD), years 11.7 (13.1) 12.7 (13.1) 11.1 (9.4) 11.8 (12.0) .82
Co-morbid Insomnia No. (%) 39 (88.6) 44 (97.8) 40 (90.9) 123 (92.5) .45
Number of co-morbid problems, mean
(SD)
2.8 (2.3) 3.7 (2.2) 3.5 (2.2) 3.4 (2.3) .17
Sleep medication use at pre-assessment,
No. (%)
20 (45.5) 14 (31.1) 25 (56.8) 59 (44.3) .05
a P values are based on analysis of variance or X
2 tests
b more than 1 choice possible
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assessments, bibliotherapy with therapist support now
produced larger gains in all sleep timing measures, com-
pared to waiting. However, only the difference in sleep
efficiency remained between bibliotherapy with and
without support. Finally, differences between bibliother-
apy and waiting now included total sleep time, as well
as the earlier differences seen in sleep onset latency and
sleep efficiency.
Ancillary analyses
Subjective sleep measures, insomnia severity and sleep
quality
Two MANOVAs were conducted with questionnaire
ratings of subjective sleep as dependent variables (i.e.
insomnia severity (ISI), sleep related behaviors (SRBQ),
and dysfunctional beliefs (DBAS), and sleep diary data
concerning subjective measures of sleep; bed time stress
level and sleep quality). Both MANOVAs showed statis-
tically significant effects of interaction (pre-post: F(10,
250) = 11.358, p < .001, hp
2 = .312; pre-follow up: F(8,
252) = 7.174, p < .001, hp
2 = .185).
Separate 2 × 2 ANOVAs were performed to establish
which interactions were significant (see tables 4 and 5).
From pre- to post-assessments, bibliotherapy with
therapist support produced larger improvements in all
subjective sleep ratings than did waiting, and also larger
improvements than bibliotherapy alone. Bibliotherapy
(without therapist support) resulted in larger improve-
ments than did waiting, in all aspects but bed time
stress levels. At three-month follow-up, all changes were
maintained in the two treatment groups, and the differ-
ences between groups remained stable.
Day-time functioning and psychological distress
Two MANOVAs were conducted with diary ratings of
day-time functioning (i.e. Positive Day Time Ratings and
Day Time Fatigue), and questionnaire ratings of per-
ceived stress (PSS) and psychological distress (CORE-
OM) as dependent variables. Both MANOVAs showed
statistically significant effects of interaction (pre-post: F
(8, 252) = 3.724, p < .001, hp
2 = .106; pre-follow up: F(8,
252) = 2.193, p = .029, hp
2 = .065).
Again, separate 2 × 2 analyses were performed to
establish which interactions were significant (see tables
6 and 7). From pre- to post-assessments, bibliotherapy
with therapist support produced larger improvements
on all measures of day-time functioning and psychologi-
cal distress than did waiting, and also larger improve-
ments than bibliotherapy alone in all aspects but
perceived stress. Bibliotherapy alone did not result in
larger improvements in these measures compared to
waiting. At three-month follow-up the differences
between bibliotherapy with support and waiting
remained stable, with the exception of psychological dis-
tress. The bibliotherapy groups, with or without support,
now had similar improvements in all measures. At this
assessment point, participants who had received bib-
liotherapy without support had improved more on day-
time ratings and fatigue than participants in the waiting
list control condition.
Co-morbidity and outcome
At post-treatment, the correlation between total number
of co-morbid problems and ISI change scores was small
but significant and negative (r(87) = -0.22, p = .040). In
other words, larger number of co-morbid problems was
associated with slightly lower improvements in insomnia
severity. This association was not significant at three-
month follow-up (r(79) = -0.19, p = .095).
To find out if specific co-morbid conditions affected
treatment outcome, ANOVAs were performed for the
more prevalent co-morbid conditions (i.e. allergy, acute
pain, stress, restless legs, nightmares, snoring, bruxism,
high blood pressure, chronic pain, nocturia, tinnitus,
depression, and anxiety) with ISI as the dependent vari-
able. To increase stability of measurement for each diag-
nosis, individuals whose problem could not be clearly
verified or ruled out at the assessment interview were
not included in these analyses. ANOVAs showed signifi-
cant main effects of group only for chronic pain (F(1,
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Figure 2 Proportion of treatment responders and remitters
according to treatment group. (a) Treatment response defined as
a change score on the Insomnia Severity Index of 8 points or more
from pre-treatment. (b) Treatment remission defined as an Insomnia
Severity Index score of less than 8 points.
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.011), i.e. individuals with chronic pain or stress pro-
blems suffered more severe insomnia at all occasions.
Only individuals with nightmares responded to the
treatment with less marked improvements on the ISI, as
seen by an interaction effect for nightmares (F(1.83, 221.27)
= 3.566, p = .034).
Sleep medication use
Out of 59 individuals using sleep medication at pre-
assessment (see table 1), 21 had ceased sleep medication
at the post-assessment interviews. Relatively few of
these, 4 out of 25 (16.7%) and 3 out of 14 (21.4%), were
found in the waiting list and bibliotherapy groups
respectively, compared to 14 out of 20 (70%) in the
group receiving bibliotherapy with therapist support.
This advantage for the group receiving bibliotherapy
with therapist support was significant (c
2 = 15.179, df =
2, p > .001, N = 58).
To control for the possibility that non-users started to
use sleep medication during treatment, the total number
of participants using sleep medication post-treatment
was also compared. In this analysis, 7 were found in the
Table 2 Sleep timing measures, Mean (SD), Change values and Effect Sizes
Pre Post Fu3 Change Pre to Post Change Pre to Fu3
Mean
(SD)
Mean
(SD)
Mean
(SD)
Mean (95% CI) Effect size (d)
a
Mean (95% CI) Effect size
(d)
Sleep Onset Latency, minutes
Bibliotherapy with support (n =
44)
60.3 (41.0) 24.9 (17.0) 33.5 (22.6) -35.4 (-46.6 to
-24.2)
-1.13 -26.8 (-39.0 to
-14.5)
-0.81
Bibliotherapy (n = 45) 65.7 (45.1) 45.1 (32.2) 43.0 (28.4) -20.6 (-30.6 to
-10.6)
-0.53 -22.7 (-34.8 to
-10.5)
-0.60
Wait-list control (n = 43) 66.9 (42.1) 62.2 (42.4) 62.4 (45.1) -4.6 (-10.7 to 1.5) -0.11 -4.5 (-12.0 to 3.0) -0.10
Wake After Sleep Onset, minutes
Bibliotherapy with support (n =
44)
53.6 (40.4) 17.0 (16.8) 26.8 (29.3) -36.5 (-47.7 to
-25.4)
-1.18 -26.8 (-38.9 to
-14.6)
-0.76
Bibliotherapy (n = 45) 47.5 (33.6) 32.0 (27.0) 30.2 (28.7) -15.6 (-24.6 to -6.5) -0.51 -17.4 (-26.6 to -8.2) -0.55
Wait-list control (n = 43) 36.9 (29.5) 30.4 (28.9) 25.3 (25.0) -6.5 (-12.5 to -0.4) -0.22 -11.6 (-19.4 to -3.7) -0.42
Total Sleep Time, hours
Bibliotherapy with support (n =
44)
5.56 (1.44) 6.07 (1.02) 6.52 (0.95) 0.51 (0.20 to 0.83) 0.41 0.97 (0.56 to 1.37) 0.79
Bibliotherapy (n = 45) 5.73 (0.89) 6.22 (1.02) 6.46 (0.96) 0.49 (0.26 to 0.73) 0.51 0.73 (0.46 to 1.00) 0.79
Wait-list control (n = 43) 6.40 (1.09) 6.55 (1.26) 6.74 (1.11) 0.14 (-0.14 to 0.42) 0.13 0.34 (0.09 to 0.59) 0.31
Sleep Efficiency, %
Bibliotherapy with support (n =
44)
67.1 (15.5) 85.4 (6.8) 83.3 (8.3) 18.3 (14.4 to 22.2) 1.53 16.2 (11.7 to 20.6) 1.30
Bibliotherapy (n = 45) 68.3 (11.1) 76.4 (10.9) 78.4 (9.8) 8.1 (5.8 to 10.3) 0.74 10.1 (7.6 to 12.6) 0.96
Wait-list control (n = 43) 71.5 (11.2) 74.5 (11.5) 76.1 (10.5) 3.0 (0.5 to 5.4) 0.27 4.5 (1.8 to 7.2) 0.42
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment
a Effect sizes calculated within groups, pre-post, and pre-fu3, with pooled SDs. (A negative effect size represents a decrease in the measure, a positive effect size
an increase.)
Table 3 Sleep timing measures, interactions between groups
Pre to Post Pre to Fu3
BTS v/s WL BTS v/s BT BT v/s WL BTS v/s WL BTS v/s BT BT v/s WL
p Effect size
(hp
2)
a
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
SOL <
.001
0.21 .06 0.04 .01 0.08 .003 0.10 .64 0.00 .02 0.07
WASO <
.001
0.20 .005 0.09 .11 0.03 .04 0.05 .23 0.02 .35 0.01
TST .09 0.03 .92 0.00 .06 0.04 .01 0.07 .34 0.01 .04 0.05
SE <
.001
0.33 <
.001
0.19 .004 0.09 <
.001
0.19 .02 0.06 .004 0.09
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment; BTS, Bibliotherapy with support; WL, Waiting
list control group; BT, Bibliotherapy; SOL, Sleep Onset Latency; WASO, Wake After Sleep Onset; TST, Total Sleep Time; SE, Sleep Efficiency
a hp
2 (Eta 2) is interpreted as explained variance in the sample
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Page 8 of 13group receiving therapist support, 11 in the bibliother-
apy only group, and 21 in the waiting list control group,
and this difference was significant (c
2 = 12.181, df = 2,
p = .002, N = 132). At three-month follow-up assess-
ment, 7 participants in the group receiving therapist
support used sleep medication, which was significantly
lower than 15 in the bibliotherapy group, and 19 in the
waiting list control group (c
2 = 8.355, df = 2, p = .015,
N = 130).
Adverse events
The most important adverse event was one individual in
the treatment group with support who dropped out of
treatment due to increased pain as an effect of sleep
restriction. In all, 23 individuals in the treatment groups
reported one adverse event and 2 individuals reported
two adverse events. More specifically, 9 felt that sleep
restriction made them more tired or was too demand-
ing, 2 individuals in the treatment group without sup-
port dropped out of treatment because some part of the
treatment was too demanding, 3 felt the sleep diary
increased their sleep related concerns, or was too
demanding to fill out, 4 did not agree with the sug-
gested life-style changes or sleep-wake rhythm, another
2 had trouble sleeping when ceasing sleep medication,
and 1 experienced increases in other problems when
sleep was no longer a problem. The remaining 5 experi-
enced slight adverse experiences, such as having a hard
time not watching TV in bed, or not drinking coffee in
the evenings, and one reported having problems in that
their sleep was so sound after treatment that they did
not hear the alarm in the morning.
Table 4 Subjective sleep measures; Mean (SD), Change values and Effect Sizes
Pre Post Fu3 Change Pre to Post Change Pre to Fu3
Mean
(SD)
Mean
(SD)
Mean
(SD)
Mean (95% CI) Effect size
(d)
a
Mean (95% CI) Effect size
(d)
Insomnia Severity Index
Bibliotherapy with support (n = 44) 17.5 (3.5) 7.6 (4.5) 8.4 (5.1) -9.9 (-11.3 to -8.5) -2.46 -9.1 (-10.7 to -7.5) -2.08
Bibliotherapy (n = 45) 16.6 (3.8) 11.2 (4.2) 10.4 (4.8) -5.3 (-6.6 to -4.0) -1.35 -6.2 (-7.5 to -4.8) -1.43
Waiting list control group (n = 44) 16.7 (3.7) 15.6 (4.7) 14.2 (4.7) -1.1 (-2.2 to 0.0) -0.26 -2.5 (-3.5 to -1.5) -0.59
Sleep Related Behaviours Questionnaire
Bibliotherapy with support (n = 44) 83.6 (14.5) 57.8 (16.4) 58.5 (16.0) -25.8 (-30.4 to
-21.2)
-1.67 -25.1 (-29.8 to
-20.8)
-1.64
Bibliotherapy (n = 45) 77.1 (12.8) 66.6 (16.0) 61.5 (17.5) -10.5 (-14.1 to
-6.9)
-0.72 -15.6 (-20.5 to
-10.7)
-1.02
Waiting list control group (n = 44) 83.4 (12.8) 79.5 (13.8) 76.9 (13.6) -3.9 (-6.9 to -0.9) -0.29 -6.5 (-9.4 to -3.5) -0.49
Dysfunctional Beliefs and Attitudes about
Sleep
Bibliotherapy with support (n = 44) 125.2
(31.3)
58.0 (30.8) -* -67.2 (-77.0 to
-57.4)
-2.17 - * - *
Bibliotherapy (n = 45) 116.0
(31.8)
85.8 (37.0) - -30.1 (-41.4 to
-18.9)
-0.88 - -
Waiting list control group (n = 44) 133.5
(31.1)
122.7
(30.7)
- -10.8 (-16.2 to
-5.4)
-0.35 - -
Bed Time Stress
b
Bibliotherapy with support (n = 44) 1.5 (1.1) 0.49 (0.74) 0.55 (0.88) -1.03 (-1.34 to
-0.72)
-1.08 -0.97 (-1.29 to
-0.64)
-0.95
Bibliotherapy (n = 45) 0.80 (0.92) 0.68 (0.85) 0.52 (0.74) -0.12 (-0.34 to
0.10)
-0.14 -0.28 (-0.51 to
-0.06)
-0.36
Waiting list control group (n = 43) 1.2 (1.1) 1.1 (1.1) 1.1 (1.1) -0.05 (-0.33 to
0.22)
-0.09 -0.08 (-0.33 to
0.16)
-0.09
Sleep Quality
c
Bibliotherapy with support (n = 44) 2.6 (0.66) 3.6 (0.65) 3.5 (0.71) 1.0 (0.75 to 1.2) 1.53 0.93 (0.68 to 1.2) 1.31
Bibliotherapy (n = 45) 2.6 (0.53) 3.1 (0.57) 3.1 (0.65) 0.57 (0.39 to 0.75) 0.91 0.53 (0.32 to 0.75) 0.84
Waiting list control group (n = 43) 2.9 (0.56) 3.0 (0.66) 3.1 (0.61) 0.11 (-0.07 to
0.28)
0.16 0.20 (0.03 to 0.36) 0.34
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment,
a Effect sizes calculated within groups, pre-post, and pre-fu3, with pooled SDs. (A negative effect size represents a decrease in the measure, a positive effect size
an increase.)
b Scored on a scale 0-5, with 0 indicating no stress at all, and 5 indicating very high stress
c Scored on a scale 1-5, with 1 indicating very poor sleep quality, and 5 indicating very good sleep quality
* DBAS-data missing from 3-month follow-up
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In this study, we demonstrate that using a self-help
book to deliver a CBT-treatment can markedly reduce
insomnia severity, and improve sleep and day-time func-
tioning, in adults with insomnia and co-morbid
problems. The effects can be enhanced by adding brief,
structured weekly therapist support over the telephone.
As hypothesized, the results show that self-help bib-
liotherapy had a strong positive effect on sleep in this
group of participants with insomnia and co-morbid
Table 5 Subjective sleep measures; Interactions
Pre to Post Pre to Fu3
BTS v/s WL BTS v/s BT BT v/s WL BTS v/s WL BTS v/s BT BT v/s WL
p Effect size
(hp
2)
a
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
p Effect size
(hp
2)
ISI <
.001
0.52 <
.001
0.20 <
.001
0.21 <
.001
0.36 .006 0.08 <
.001
0.18
SRBQ <
.001
0.42 <
.001
0.23 .007 0.08 <
.001
0.33 .008 0.08 <
.002
0.10
DBAS <
.001
0.53 <
.001
0.21 .003 0.10 -* - - - - -
Bed Time
Stress
<
.001
0.20 <
.001
0.20 .71 0.00 <
.001
0.18 .001 0.12 .23 0.02
Sleep Quality <
.001
0.27 .008 0.08 <
.001
0.13 <
.001
0.21 .02 0.06 .02 0.06
Abbreviations: Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment; BTS, Bibliotherapy with
support; WL, Waiting list control group; BT, Bibliotherapy; ISI, Insomnia Severity Index; SRBQ, Sleep Related Behaviours Questionnaire; DBAS, Dysfunctional Beliefs
and Attitudes about Sleep
a hp
2 (Eta-2) is interpreted as explained variance in the sample
* DBAS-data missing from 3-month follow-up
Table 6 Day time functioning and psychological distress; Mean (SD), Change values and Effect sizes
Pre Post Fu3 Change Pre-Post Change Pre-Fu3
Mean
(SD)
Mean
(SD)
Mean
(SD)
Mean (95% CI) Effect size (d)
a
Mean (95% CI) Effect size (d)
a
Positive Day Time Ratings
Bibliotherapy with support (n =
44)
2.5 (0.79) 3.2 (0.70) 3.1 (0.74) 0.69 (0.46 to 0.92) 0.94 0.58 (0.34 to 0.82) 0.78
Bibliotherapy (n = 45) 2.6 (0.65) 3.0 (0.72) 3.0 (0.84) 0.38 (0.19 to 0.58) 0.58 0.44 (0.21 to 0.67) 0.58
Waiting list control (n = 43) 2.6 (0.73) 2.8 (0.75) 2.7 (0.76) 0.17 (-0.02 to 0.36) 0.27 0.13 (-0.07 to 0.32) 0.13
Day Time Fatigue (DTF)
Bibliotherapy with support (n =
44)
2.8 (0.98) 1.5 (1.0) 1.8 (1.1) -1.23 (-1.54 to
-0.91)
-1.31 -0.98 (-1.3 to -0.66) -0.96
Bibliotherapy (n = 45) 2.7 (0.82) 2.2 (0.99) 2.1 (0.94) -0.49 (-0.81 to
-0.17)
-0.55 -0.61 (-0.92 to
-0.31)
-0.68
Waiting list control (n = 43) 2.7 (0.82) 2.4 (0.89) 2.6 (1.0) -0.28 (-0.50 to
-0.05)
-0.35 -0.14 (-0.42 to
0.13)
-0.11
Perceived Stress Scale (PSS)
Bibliotherapy with support (n =
44)
17.4 (7.4) 13.1 (5.7) 13.2 (5.9) -4.3 (-6.0 to -2.6) -0.65 -4.2 (-6.1 to -2.3) -0.63
Bibliotherapy (n = 45) 18.8 (6.2) 16.1 (7.1) 15.1 (7.4) -2.7 (-4.2 to -1.1) -0.41 -3.6 (-5.2 to -2.0) -0.54
Waiting list control (n = 44) 19.0 (6.8) 17.2 (6.3) 17.3 (7.2) -1.8 (-3.0 to -0.6) -0.27 -1.7 (-3.3 to -0.2) -0.24
CORE-OM
Bibliotherapy with support (n =
44)
37.0 (17.7) 24.4 (14.0) 27.2 (17.0) -12.5 (-17.0 to -8.0) -0.79 -9.7 (-14.7 to -4.7) -0.56
Bibliotherapy (n = 45) 36.7 (15.8) 32.5 (16.1) 29.6 (15.4) -4.2 (-8.5 to 0.1) -0.26 -7.1 (-11.6 to -2.7) -0.46
Waiting list control (n = 44) 41.7 (15.6) 36.2 (15.3) 36.0 (18.4) -5.5 (-8.9 to-2.0) -0.36 -5.7 (-9.6 to -1.7) -0.33
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment; CORE-OM, The Clinical Outcomes in Routine
Evaluation-Outcome Measure
a Effect sizes calculated within groups, pre-post, and pre-fu3, with pooled SDs. (A negative effect size represents a decrease in the measure, a positive effect size
an increase.)
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Page 10 of 13problems. The effects were manifest both for remission
rates, sleep timing and subjective measures of sleep as
well as for ratings of day-time functioning. Gains seen
immediately after treatment were to a large extent main-
tained three months later.
Therapist supported treatment produced larger overall
effects at post-treatment as well as at three-month fol-
low-up, compared to treatment without therapist sup-
port or no treatment. The number of participants with
clinically significant improvements in insomnia severity
(i.e. responders and remitters) was larger, effects on
sleep, day-time functioning and perceived stress were
larger, and medication use was greatly reduced in the
group receiving therapist support as compared to the
group not receiving therapist support, and the waiting
list control group. Although the difference compared to
treatment without support was somewhat attenuated at
three-month follow-up, participants in the therapist-sup-
ported group were still better off in several important
aspects. In contrast, Mimeault and coworkers found the
extra effect of brief therapist contact to become negligi-
ble at three-month follow-up [29]. However, our find-
ings are in line with the Van Straten & Cuijpers meta-
analysis of self-help treatments of insomnia [17], as well
as research in self-help for areas such as depression and
anxiety, and support the notion that therapist contact
with participants does enhance treatment outcome [28].
The effect of therapist support is impressive consider-
ing its limited amount (15 minutes per week for 6
weeks) and the fact that the support took place over the
telephone. In fact, effects in this group compare well to
those demonstrated for primary insomnia, both in a
recent study of CBT group-therapy and CBT + medica-
tion [38], and in a meta-analysis on CBT and medica-
tion [13]. This may be due to the high level of structure
of the telephone calls, focusing on sleep restriction and
stimulus control. In contrast, bibliotherapy without
therapist support produced slightly lower effect sizes for
most measures, comparable to those seen previously in
self-help treatments for insomnia [17].
Considering that the majority of patients with insom-
nia also suffer from co-morbid problems [22,46], the
present findings of positive treatment effects in insom-
nia severity in a group with heterogeneous co-morbid
problems may be of great importance. It should be
noted, however, that larger number of co-morbid pro-
blems was associated with slightly lower improvements
in insomnia severity. Although only 4% of the variance
in outcome was explained by co-morbidity, the findings
point at a need to further evaluate the influence of co-
morbid disorders. For instance, studies evaluating the
effect of CBT for insomnia for specific combinations of
insomnia and co-morbid conditions are needed. One
possibility is to develop and test combined manuals. For
example, in the present study, individuals with night-
mares experienced significantly lower gains from treat-
ment, which could indicate a need to improve the
treatment for this rather large group. Since specific
treatments of nightmares have already been developed
(e.g. Imagery Rehearsal Therapy [47]), evaluating the
effect of IRT on insomnia symptoms, and combining
CBT for insomnia and IRT protocols for this group
should be considered for individuals with both insomnia
and nightmares. As mentioned earlier, Mimeault and
co-workers [29] did not find lasting differences between
the groups receiving support and not. However, only
participants with primary in s o m n i aw e r ei n c l u d e di n
that study. The findings in the present study could indi-
cate that individuals with co-morbid disorders may ben-
efit more from therapist support than do individuals
with primary insomnia. From a clinical point of view,
such a relation would be of great importance and merits
further investigation.
Several limitations should be noted in the present
study; e.g. the use of self-reports as opposed to objective
sleep timing measures. Although sleep diaries represent
Table 7 Day time functioning and psychological distress; Interactions
Pre to Post Pre to Fu3
BTS v/s WL BTS v/s BT BT v/s WL BTS v/s WL BTS v/s BT BT v/s WL
P Effect size
(hp
2)
a
p Effect size
(hp
2)
a
p Effect size
(hp
2)
a
p Effect size
(hp
2)
a
p Effect size
(hp
2)
a
p Effect size
(hp
2)
a
Positive
DTR
.001 0.12 .05 0.04 .13 0.03 .005 0.09 .42 0.01 .04 0.05
DTF <
.001
0.21 .002 0.11 .28 0.01 <
.001
0.15 .11 0.03 .03 0.06
PSS .02 0.06 .16 0.02 .40 0.01 .05 0.04 .66 0.00 .10 0.03
CORE-OM .02 0.06 .01 0.07 .65 0.00 .22 0.02 .45 0.01 .63 0.00
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; Fu3, 3-month follow-up assessment; BTS, Bibliotherapy with support; WL, Waiting
list control group; BT, Bibliotherapy; Positive DTR, Positive Day Time Ratings; DTF, Day Time Fatigue; PSS, Perceived Stress Scale; CORE-OM, The Clinical Outcomes
in Routine Evaluation-Outcome Measure
a hp
2 (Eta 2) is interpreted as explained variance in the sample
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Page 11 of 13a core assessment component in insomnia research [48],
patients with insomnia generally over-estimate wake-
time [49]. Nonetheless, sleep diaries have been shown to
correlate well with objective measures [50]. It is likely
that these results can be compared to those of other
studies using sleep diaries, but objective measures, such
as polysomnography or actigraphs, would be needed to
confirm objective changes in sleep. Since we were inter-
ested in maximizing generalizability, selection criteria
were liberal, which yielded a heterogeneous sample. A
concern regarding generalization is that our participants
had a high education level, and generally a good or at
least adequate economic situation. Finally, the power
calculation was based on the expected difference in
effect between the two treatments and the wait list con-
trol group, and it cannot be excluded that the present
study was not adequately powered to fully investigate
the differences between the two active treatment arms.
The study also has several strengths. We used an
untreated group to control for fluctuations over time up
until five months after the beginning of treatment, and
analyzed interactions to control for changes not due to
treatment. We also had a comparably large number of
participants in each treatment group, and included mea-
sures of day-time functioning, which have not been ade-
quately studied in earlier insomnia treatment research.
The heterogeneous sample extends previous positive
findings on individuals with primary insomnia to also
include the typical insomnia patient with co-morbid
problems.
Conclusions
Self-help CBT-based bibliotherapy can effectively allevi-
ate insomnia in a self-recruited sample with a wide
range of co-morbid disorders. Brief structured guidance
from a therapist enhanced outcome, and treatment
gains as well as differences between groups were largely
maintained three months after the end of treatment. In
particular when considering its potential for being easily
distributed and low in cost, self-help CBT alone or with
brief therapist support is likely to help the large group
of individuals with insomnia including those with co-
morbid problems.
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